NASDAQ:JAGX Jaguar Health (JAGX) Stock Forecast, Price & News $0.66 -0.01 (-1.50%) (As of 06/8/2023 ET) Add Compare Share Share Today's Range$0.64▼$0.6850-Day Range$0.48▼$0.9852-Week Range$0.46▼$28.50Volume369,963 shsAverage Volume2.29 million shsMarket Capitalization$9.08 millionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileProfileChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaProfileChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media About Jaguar Health (NASDAQ:JAGX) StockJaguar Health, Inc., a commercial stage pharmaceuticals company, focuses on developing prescription medicines for people and animals with gastrointestinal distress, specifically chronic and debilitating diarrhea. The company operates through two segments, Human Health and Animal Health. It markets Mytesi for the symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy. The company also develops Crofelemer, which is in Phase 3 clinical trial for or prophylaxis of diarrhea in adult cancer patients, and to address rare/orphan disease indications, including Short bowel syndrome with intestinal failure and/or congenital diarrheal disorders; supportive care for diarrhea relief in inflammatory bowel diseases; diarrhea-predominant irritable bowel syndrome; and for idiopathic/functional diarrhea. In addition, it develops NP-300, a second-generation proprietary anti-secretory antidiarrheal drug for symptomatic relief and treatment of moderate-to-severe diarrhea; and Canalevia, an oral plant-based drug candidate to treat chemotherapy-induced diarrhea in dogs and exercise-induced diarrhea in dogs. The company was founded in 2013 and is headquartered in San Francisco, California.Read More Receive JAGX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Jaguar Health and its competitors with MarketBeat's FREE daily newsletter. Email Address JAGX Stock News HeadlinesJune 8, 2023 | finanznachrichten.deJaguar Health, Inc.: Canine and Child Cancer Research Advocates Call for Support as Capitol Hill "Goes to the Dogs"June 8, 2023 | finance.yahoo.comCanine and Child Cancer Research Advocates Call for Support as Capitol Hill "Goes to the Dogs"June 8, 2023 | Legacy Research (Affiliate) (Ad)Sell Every Stock, Except ONE (Ticker Revealed)We saw one of the longest bull markets in history, with the S&P surging well over 800% But now the chickens have come home to roost. However, Jeff Clark couldn’t care less because he ignores almost every single stock in the market.June 7, 2023 | finance.yahoo.comEuropean Pharmaceutical Industry Leader and Entrepreneur Massimo Radaelli, PhD Named Commander of the Italian Republic for Special MeritsMay 30, 2023 | americanbankingnews.comJaguar Health (NASDAQ:JAGX) Lowered to "Sell" at StockNews.comMay 25, 2023 | finanznachrichten.deJaguar Health, Inc.: Take C.H.A.R.G.E. Registry Marks One-Year Anniversary on National Canine Cancer Awareness Day, With Database Grown 40%May 24, 2023 | finanznachrichten.deJaguar Health, Inc.: Board Certified Patient Advocate Stacey Tinianov, MPH, Joins Jaguar Health's Scientific Advisory BoardMay 24, 2023 | finance.yahoo.comBoard Certified Patient Advocate Stacey Tinianov, MPH, Joins Jaguar Health's Scientific Advisory BoardJune 8, 2023 | Behind the Markets (Ad)Laser breakthrough could send stock soaring 2,467%Laser breakthrough could send stock soaring 2,476% Whenever the military develops a breakthrough technology, timely investors could see groundbreaking returns. General Dynamics returned 8,990%... Boeing soared 4,238%... L3Harris shot up 1,628%...May 23, 2023 | finance.yahoo.comTake C.H.A.R.G.E. Registry Marks One-Year Anniversary on National Canine Cancer Awareness Day, With Database Grown 40%May 22, 2023 | americanbankingnews.comStockNews.com Upgrades Jaguar Health (NASDAQ:JAGX) to HoldMay 17, 2023 | finance.yahoo.comJaguar Health First Quarter 2023 Earnings: US$2.39 loss per share (vs US$30.17 loss in 1Q 2022)May 16, 2023 | finanznachrichten.deJaguar Health, Inc.: Jaguar Health Reports First Quarter 2023 Financial ResultsMay 16, 2023 | finanznachrichten.deJaguar Health, Inc.: Jaguar Health to Present at Lytham Partners Spring 2023 Investor Conference & Participate in Animal Health PanelMay 16, 2023 | finance.yahoo.comJaguar Health to Present at Lytham Partners Spring 2023 Investor Conference & Participate in Animal Health PanelMay 16, 2023 | finance.yahoo.comQ1 2023 Jaguar Health Inc Earnings CallMay 15, 2023 | markets.businessinsider.comHere's what Wall Street expects from Jaguar Health's earnings reportMay 15, 2023 | finance.yahoo.comJaguar Health Reports First Quarter 2023 Financial ResultsMay 14, 2023 | americanbankingnews.comJaguar Health (JAGX) Scheduled to Post Quarterly Earnings on MondayMay 13, 2023 | americanbankingnews.comJaguar Health (NASDAQ:JAGX) Upgraded at StockNews.comMay 12, 2023 | finance.yahoo.comREMINDER: Jaguar Health to Hold Investor Webcast Monday, May 15th at 8:30 AM EDT Regarding Q1 2023 Financials & Corporate UpdatesMay 10, 2023 | finanznachrichten.deJaguar Health, Inc.: Jaguar Health Launches AI-powered Web Portal to Support Patient Access to Mytesi, the Company's FDA-approved Prescription DrugMay 10, 2023 | finance.yahoo.comJaguar Health Launches AI-powered Web Portal to Support Patient Access to Mytesi, the Company's FDA-approved Prescription DrugMay 9, 2023 | marketwatch.com8-K: Jaguar Health, Inc.May 9, 2023 | finance.yahoo.comJaguar Completes Enrollment in Its Pivotal Phase 3 OnTarget Trial of Crofelemer for Prophylaxis of Cancer Therapy-Related DiarrheaMay 8, 2023 | finance.yahoo.comJaguar Health to Hold Investor Webcast Monday, May 15th at 8:30 AM EDT Regarding Q1 2023 Financials & Corporate UpdatesMay 4, 2023 | americanbankingnews.comStockNews.com Lowers Jaguar Health (NASDAQ:JAGX) to SellSee More Headlines JAGX Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart JAGX Company Calendar Last Earnings11/17/2021Today6/08/2023Next Earnings (Estimated)8/28/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Pharmaceutical preparations Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:JAGX CUSIPN/A CIK1585608 Webwww.jaguaranimalhealth.com Phone(415) 371-8300FaxN/AEmployees60Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-47,450,000.00 Net Margins-368.66% Pretax Margin-377.14% Return on Equity-1,337.16% Return on Assets-82.36% Debt Debt-to-Equity Ratio2.29 Current Ratio1.04 Quick Ratio0.76 Sales & Book Value Annual Sales$11.96 million Price / Sales0.77 Cash FlowN/A Price / Cash FlowN/A Book Value($0.32) per share Price / Book-2.09Miscellaneous Outstanding Shares13,860,000Free Float13,840,000Market Cap$9.25 million OptionableNot Optionable Beta1.82 Key ExecutivesMs. Lisa A. Conte (Age 64)Founder, CEO, Pres & Director Comp: $771.4kDr. Pravin R. Chaturvedi Ph.D. (Age 60)Chief Scientific Officer & Chair of Scientific Advisory Board Comp: $539.04kMr. Jonathan S. Wolin CPA (Age 60)J.D., M.B.A., Chief of Staff, Chief Compliance Officer & Gen. Counsel Comp: $520.29kMr. Ian H. Wendt M.B.A. (Age 55)Chief Commercial Officer Comp: $441.31kDr. Steven R. King Ph.D. (Age 65)Chief of Sustainable Supply, Ethnobotanical Research & Intellectual Property and Sec. Comp: $477.66kMs. Carol R. Lizak M.B.A. (Age 59)Chief Financial Officer Mr. Peter HodgeSr. Director of Investor Relations, Bus. Devel. & Special EventsDr. Karen J. Brunke Ph.D. (Age 70)Exec. VP of Corp. & Bus. Devel. Mr. David SesinChief Manufacturing OfficerMore ExecutivesKey CompetitorsAddex TherapeuticsNASDAQ:ADXNCatalyst BiosciencesNASDAQ:CBIOAvenue TherapeuticsNASDAQ:ATXIAridis PharmaceuticalsNASDAQ:ARDSComera Life SciencesNASDAQ:CMRAView All CompetitorsInstitutional OwnershipTwo Sigma Securities LLCSold 12,539 shares on 5/15/2023Ownership: 0.375%BlackRock Inc.Sold 600,306 shares on 5/12/2023Ownership: 0.369%Acadian Asset Management LLCBought 69,346 shares on 5/11/2023Ownership: 0.500%Simplex Trading LLCSold 4,500 shares on 4/27/2023Ownership: 0.000%View All Institutional Transactions JAGX Stock - Frequently Asked Questions How have JAGX shares performed in 2023? Jaguar Health's stock was trading at $0.0869 on January 1st, 2023. Since then, JAGX stock has increased by 668.1% and is now trading at $0.6675. View the best growth stocks for 2023 here. Are investors shorting Jaguar Health? Jaguar Health saw a increase in short interest during the month of May. As of May 15th, there was short interest totaling 2,950,000 shares, an increase of 163.4% from the April 30th total of 1,120,000 shares. Based on an average daily volume of 3,550,000 shares, the short-interest ratio is presently 0.8 days. View Jaguar Health's Short Interest. When is Jaguar Health's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, August 28th 2023. View our JAGX earnings forecast. How were Jaguar Health's earnings last quarter? Jaguar Health, Inc. (NASDAQ:JAGX) issued its quarterly earnings results on Wednesday, November, 17th. The biotechnology company reported ($0.27) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.18) by $0.09. The biotechnology company had revenue of $0.63 million for the quarter. Jaguar Health had a negative trailing twelve-month return on equity of 1,337.16% and a negative net margin of 368.66%. During the same quarter last year, the business posted ($0.63) earnings per share. When did Jaguar Health's stock split? Jaguar Health shares reverse split before market open on Wednesday, September 8th 2021. The 1-3 reverse split was announced on Wednesday, September 8th 2021. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, September 8th 2021. An investor that had 100 shares of stock prior to the reverse split would have 33 shares after the split. What other stocks do shareholders of Jaguar Health own? Based on aggregate information from My MarketBeat watchlists, some companies that other Jaguar Health investors own include Biocept (BIOC), Sorrento Therapeutics (SRNE), Trevena (TRVN), Vaxart (VXRT), Purple Biotech (KTOV), Onconova Therapeutics (ONTX), Tonix Pharmaceuticals (TNXP), Biopharmx (BPMX), Cara Therapeutics (CARA) and Conatus Pharmaceuticals (CNAT). When did Jaguar Health IPO? (JAGX) raised $22 million in an IPO on Wednesday, May 13th 2015. The company issued 3,200,000 shares at $7.00 per share. Aegis Capital Corp acted as the underwriter for the IPO and CRT Capital and Feltl and Company were co-managers. What is Jaguar Health's stock symbol? Jaguar Health trades on the NASDAQ under the ticker symbol "JAGX." Who are Jaguar Health's major shareholders? Jaguar Health's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Acadian Asset Management LLC (0.50%), Two Sigma Securities LLC (0.37%), BlackRock Inc. (0.37%) and Simplex Trading LLC (0.00%). View institutional ownership trends. How do I buy shares of Jaguar Health? Shares of JAGX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Jaguar Health's stock price today? One share of JAGX stock can currently be purchased for approximately $0.67. How much money does Jaguar Health make? Jaguar Health (NASDAQ:JAGX) has a market capitalization of $9.25 million and generates $11.96 million in revenue each year. How can I contact Jaguar Health? Jaguar Health's mailing address is 201 MISSION STREET SUITE 2375, SAN FRANCISCO CA, 94105. The official website for the company is www.jaguaranimalhealth.com. The biotechnology company can be reached via phone at (415) 371-8300. This page (NASDAQ:JAGX) was last updated on 6/8/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Jaguar Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.